STAT+: A new drug offers a rare option for brain cancer treatment — and inspires hopes for more
For more cancer coverage, sign up for STAT’s pop-up newsletter focused on this weekend’s European Society for Medical Oncology conference, one of the biggest oncology meetings of the year. Details here.
When Rachel Guberman found out she had brain cancer, she did so much reading and Googling about the disease that she joked she had reached the end of the internet.
But she avoided digging into one particular subject: what she might have to endure with chemotherapy and radiation.
